Unseen Capital

Unseen Capital Research Document Unseen Capital is a healthcare venture capital fund founded in 2021 with a mission to invest in early-stage healthcare companies started by underrepresented founders, particularly those building solutions at the intersection of digital health and structural determinants of health. Following a strategic acquisition by Seae Ventures in July 2024, Unseen now operates as the pre-seed/early seed vehicle within the Seae family. Investment Thesis Unseen Capital's core thesis is that innovation in healthcare comes from all corners, particularly from founders who have lived experience with healthcare inequities and understand the challenges facing marginalized communities. The fund believes in flipping the traditional adoption model for health by backing founders who are inextricably tied to the challenges at the intersection of digital health and social determinants of health. Their conviction is that helping marginalized populations first is both socially responsible and strategically sound, and that diverse founding teams drive higher returns and better health outcomes. Stage Focus & Check Size Unseen Capital focuses exclusively on early-stage investments: Pre-Seed: $250K-$500K for early-stage validation and team building Seed: $500K-$2M for companies with initial product-market validation Typical check size range: $250K-$2M Ownership targets: 10-15% per round Positioned to be the first institutional investor in promising healthcare startups Sector & Focus Areas Unseen Capital invests exclusively in healthcare and digital health sectors with emphasis on solutions serving marginalized communities: Primary Investment Areas: Digital health platforms for underserved populations Caregiving and home health technology Mental health and behavioral health solutions Gender-responsive healthcare (women's health, reproductive health, trans healthcare) Primary care and preventive health access Healthcare logistics and patient transportation Clinical trial recruitment and patient engagement Healthcare workforce training and support Healthcare access for marginalized communities (racial justice, economic justice, LGBTQ+) Target Founder Profiles: Underrepresented founders (women, BIPOC, LGBTQ+) Founders with lived experience in healthcare inequities Experienced healthcare operators transitioning to entrepreneurship Clinician founders with deep domain expertise Fund Status & Recent Activity Following the acquisition by Seae Ventures in July 2024, Unseen Capital operates as the pre-seed/early seed vehicle within the Seae family, continuing its mission under the leadership of Erica Murdock (Managing Director - Unseen). The fund maintains active deployment and portfolio management. Recent Activity (2025): October 2025: Investment in Allswell (Clinics/Outpatient Services) Active portfolio management and follow-on investments in existing portfolio companies Continued support for portfolio companies in women's health, primary care, and digital health Notable Portfolio: Alerje: Food allergy management for life-threatening allergies CareAcademy: Training platform for home care and hospice professionals Health In Her HUE: Digital health for Black women and women of color MedHaul: Non-emergency medical transportation network Nolia Health: Chronic condition management platform PeopleOne Health: Value-based primary care with zero copays Plume: Gender-affirming virtual healthcare Rezilient: Hybrid virtual/in-person primary and specialty care Trial Library: AI-powered clinical trial recruitment U-Pwr: Platform as a Service for healthcare access Violet: Provider benchmarking and health equity platform Leadership & Team Structure Unseen-Specific Leadership: Erica Murdock (Managing Director, Unseen): Former COO at Hurdle Health with 20+ years of digital health experience and healthcare operations expertise Roberto Rodriguez (Venture Partner, Unseen): Founder of Sequential Ventures, former SVB and L'Attitude Ventures team member with healthcare investment background Seae Ventures Supporting Leadership: Jason Robart (Co-founder & Managing Partner): Former CSO of Blue Cross Blue Shield of Massachusetts, CEO of Zaffre venture subsidiary Tuoyo Louis (Co-founder & Managing Partner): 20+ years finance and investment experience, founding team member of Zaffre, deep healthcare finance expertise Arianne Kidder (Partner): 20 years in healthcare finance and operations leadership Geographic Focus Primary investment geography: East Coast concentration: Boston, New York, Miami, Washington DC given Seae headquarters National reach with emphasis on underrepresented founder networks and healthcare innovation hubs Selective international focus on healthcare innovation for marginalized communities Decision Process & Founder Support Decision Process : Investment partnership with potential syndication to healthcare-focused and diversity-focused funds Decision Timeline : 2-4 weeks for pre-seed, 4-6 weeks for seed given due diligence requirements Warm Introductions : Preferred but not required given emphasis on underrepresented founder access Board Involvement : Board seat or board observer for seed+ rounds Operational Support : Founder support through healthcare operator network, GTM strategy, operations guidance Anti-Thesis Unseen Capital explicitly avoids: Healthcare companies not serving marginalized or underserved populations Companies with non-authentic diversity in founding teams Services that perpetuate healthcare inequities Purely technical healthcare tools without focus on health equity outcomes Non-healthcare applications Fund Performance & Notable Exits Exits: Quilted Health: Comprehensive pregnancy and postnatal care (Exited 2024) Fund Performance: Fund I deployed across 12+ early-stage healthcare companies Portfolio focused on women and BIPOC founders in healthcare Strong emphasis on founder diversity and healthcare innovation in underserved markets Legacy & Mission Unseen Capital was founded in 2021 to continue and expand the vision of backing underrepresented healthcare founders. Following the acquisition by Seae Ventures in July 2024, the firm remains committed to honoring this mission and ensuring that capital reaches the broadest range of healthcare entrepreneurs, particularly those from marginalized communities with lived experience solving healthcare inequities.